Longitudinal pattern of depressive symptoms around natural menopause.
Longitudinal pattern of depressive symptoms around natural menopause.
复制标题
DOI:
10.1001/jamapsychiatry.2013.2819
复制
发表时间:
2014-01
期刊:
影响因子:
25.8
通讯作者:
Zhang R
中科院分区:
文献类型:
--
作者:
Freeman EW;Sammel MD;Boorman DW;Zhang R
An increased risk of depressive symptoms has been associated with the transition to menopause, but the risk of depressive symptoms in the early postmenopausal years has not been well-characterized. Identify within-woman changes in depressive symptoms over a 14-year period around menopause, determine associations of a history of depression with the pattern of depressive symptoms and evaluate the rate of change in reproductive hormones as predictors of depressive symptoms postmenopause. A cohort of late reproductive-age women followed for 14 years with annual assessments of symptoms and reproductive hormones. Randomly-identified, population-based sample in Philadelphia County, PA 203 generally healthy women who were premenopausal at baseline and reached natural menopause in the follow-up interval. Center for Epidemiologic Studies Depression Scale (CES-D) The prevalence of high CES-D scores decreased from 10 years before menopause to 8 years postmenopause, with a decrease of approximately 15% of baseline per year (odds ratio 0.85, 95% CI: 0.81–0.89, P<0.001). Relative to the final menstrual period (FMP), the risk of depressive symptoms was greater in the years before and lower in the years following the FMP. Among women with a history of depression, the likelihood of depressive symptoms was 13 times greater overall and 8 times greater postmenopause compared to women with no depression history. Among women who first experienced depressive symptoms approaching menopause, the risk of depressive symptoms declined after the FMP, with a significantly lower risk after the second year postmenopause. The risk of depressive symptoms postmenopause decreased by 35% for each unit (SD) increase before the FMP in the log rate of change of follicle stimulating hormone (FSH) (odds ratio 0.65, 95% CI 0.46–0.91, P=0.01). The final menstrual period was pivotal in the overall pattern of decreasing depressive symptoms in mid-life women, with greater risk before and lower risk following the FMP. A history of depression strongly increased the risk both before and after menopause. Women who had no history of depression before the menopause transition had a low risk of depressive symptoms after two or more years following the FMP.